NO972290L - Fremgangsmåte for fremstilling av optisk aktive forbindelser - Google Patents

Fremgangsmåte for fremstilling av optisk aktive forbindelser

Info

Publication number
NO972290L
NO972290L NO972290A NO972290A NO972290L NO 972290 L NO972290 L NO 972290L NO 972290 A NO972290 A NO 972290A NO 972290 A NO972290 A NO 972290A NO 972290 L NO972290 L NO 972290L
Authority
NO
Norway
Prior art keywords
preparation
optically active
active compounds
methylquinoline
tetrahydro
Prior art date
Application number
NO972290A
Other languages
English (en)
Other versions
NO972290D0 (no
Inventor
Jozsef Balint
Gyoergy Fetter
Elemer Fogassy
Antal Friesz
Antal Gajary
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of NO972290D0 publication Critical patent/NO972290D0/no
Publication of NO972290L publication Critical patent/NO972290L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det beskrives fremstilling av det nye, optiske mellomprodukt (-)-6- fluor-1,2,3,4-tetrahydro-2-metylkinolin med den generelle formel (I) og dets salter i hvilken det racemiske 6-fluor- 1,2,3,4-tetrahydro-2-metylkinolin eller dets salt oppløses med L-(-)-a-bromkam- fer-Ti-sulfonsyren med den generelle formel (III) eller dens salt.
NO972290A 1996-05-21 1997-05-20 Fremgangsmåte for fremstilling av optisk aktive forbindelser NO972290L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9601361A HUP9601361A3 (en) 1996-05-21 1996-05-21 Process for producing optically active compounds

Publications (2)

Publication Number Publication Date
NO972290D0 NO972290D0 (no) 1997-05-20
NO972290L true NO972290L (no) 1997-11-24

Family

ID=89993985

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972290A NO972290L (no) 1996-05-21 1997-05-20 Fremgangsmåte for fremstilling av optisk aktive forbindelser

Country Status (3)

Country Link
EP (1) EP0819677A1 (no)
HU (1) HUP9601361A3 (no)
NO (1) NO972290L (no)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1366683A (en) * 1971-05-06 1974-09-11 Pfizer Ltd Substituted tetrahydroquinolines
BE793524A (fr) * 1971-12-30 1973-06-29 Riker Laboratories Inc Acides benzoquinolizine-carboxyliques et leurs derives
IT1111918B (it) * 1979-04-10 1986-01-13 Riker Laboratories Inc Medicamento veterinario a base di acidi benzochinolizin carbossilici e loro derivati

Also Published As

Publication number Publication date
NO972290D0 (no) 1997-05-20
HU9601361D0 (en) 1996-07-29
HUP9601361A3 (en) 1999-04-28
HUP9601361A2 (hu) 1998-03-02
EP0819677A1 (en) 1998-01-21

Similar Documents

Publication Publication Date Title
DK0574313T3 (da) 1,4-disubstituerede piperaziner til behandling af sygdomme i centralnervesystemet og neuroendocrine sygdomme
ATE208389T1 (de) Verfahren zur herstellung von enantiomerenreinen tropasäureestern
DE59309819D1 (de) Verwendung von 2-(N-(2-Aminoethyl)amino)-essigsäure-derivaten zur Behandlung von Erkrankungen, die durch die nichtenzymatische Glykosylierung bedingt sind
EP0725074A3 (en) Intermediate compounds for the preparation of androst-3,5-diene-3-carboxy derivatives
ATE122042T1 (de) Pyrazoloisoquinoline-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DK390587A (da) 7-oeoe3-aminomethyl-3-alkylaa-1-pyrrolidinylaa-quino lin-carboxylsyre
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE3785878D1 (de) 3,4-disubstituierte-2-azetidinon-derivate und verfahren zu ihrer herstellung.
DE3368414D1 (en) 1,4-dihydropyridines, processes for their preparation and their use in medicines
DE3673468D1 (de) N-alkyl-2,6-dimethylmorpholinio-carbonsaeureamid-salze, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
EP0806421A4 (en) DERIVATIVES OF CHINOLINE CARBONIC ACID
DE59002880D1 (de) Kristalline cephem saeureadditionssalze und verfahren zu ihrer herstellung.
GR3001708T3 (en) 1-phenylimidazole-carbon acid amides, process for their preparation and their use as growth regulators
NO972291L (no) Fremgangsmåte for fremstilling av optisk aktive forbindelser
NO955112L (no) Fremgangsmåte for fremstilling av oksazolidinkarboksylsyre samt anvendelse derav for fremstiling av terapeutisk aktive taxoider
ATE399152T1 (de) Verfahren zur herstellung von optisch aktiven azetidin-2-carbonsäuren
DE69332821D1 (de) Optisch aktives 2-nitroimidazolderivat, verfahren zu seiner herstellung und ein intermediat zu seiner herstellung
ATE113840T1 (de) Verwendung einer verbindung zur herstellung eines arzneimittels zur senkung des harnsäuregehalts des blutes.
AU588414B2 (en) Methionine-substituted 1, 4-dihydropyridines, process for the preparation and their use
DE60005525D1 (de) 2-aminotetraline zur behandlung von glaukom
ATE33837T1 (de) Azolylmethylcycloacetale, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE111093T1 (de) Verfahren zur herstellung von enantiomeren von 3- aminchromanderivaten.
EP1170287A4 (en) METHOD FOR PRODUCING OPTICALLY ACTIVE, N-SUBSTITUTED AZETIDINE-2-CARBONIC ACIDS
NO931602L (no) Nye enantiomerer avledet fra (s)-2-amino-2-(3,4-diklorbenzyl)-1-propanol
RU94046014A (ru) Диаминовые соли клавулановой кислоты